Matches in Wikidata for { <http://www.wikidata.org/entity/Q65358173> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q65358173 description "clinical trial" @default.
- Q65358173 description "ensayu clínicu" @default.
- Q65358173 description "klinisch onderzoek" @default.
- Q65358173 description "клінічне випробування" @default.
- Q65358173 description "կլինիկական փորձարկում" @default.
- Q65358173 name "A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma" @default.
- Q65358173 name "A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma" @default.
- Q65358173 type Item @default.
- Q65358173 label "A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma" @default.
- Q65358173 label "A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma" @default.
- Q65358173 prefLabel "A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma" @default.
- Q65358173 prefLabel "A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma" @default.
- Q65358173 P1050 Q65358173-BC1A5941-1DF0-43D8-B95D-D3A2A6AEEAE6 @default.
- Q65358173 P1132 Q65358173-F380C70F-F0FC-4A46-8239-57A8CAED096A @default.
- Q65358173 P1476 Q65358173-F8CA7B6E-C831-4A31-AA25-8A7309A995CB @default.
- Q65358173 P17 Q65358173-F5172DDA-2226-400B-AA8A-7332C551D5CF @default.
- Q65358173 P2899 Q65358173-EBEF68B6-D85B-4465-9654-3B1F6B12D9ED @default.
- Q65358173 P3098 Q65358173-FE4261F6-885B-4D82-B7F1-C2FC75821763 @default.
- Q65358173 P31 Q65358173-4191ACBF-0A1B-4936-B2A7-7B07820B2553 @default.
- Q65358173 P4844 Q65358173-1A55ED5B-53F1-4C07-A198-0AA7C00C2FCC @default.
- Q65358173 P4844 Q65358173-272E6392-E5F8-40BC-A240-CAA25A532103 @default.
- Q65358173 P580 Q65358173-7DF03E4C-DE23-4568-A452-D89DA60FCCF4 @default.
- Q65358173 P582 Q65358173-0C42D354-0A5F-4CCB-B0D2-B0F5A43B5E39 @default.
- Q65358173 P6099 Q65358173-92573A47-D86D-4F33-ACD6-F570B90576EF @default.
- Q65358173 P6153 Q65358173-27DC5788-0A49-4A53-88E6-57A3C1A1635E @default.
- Q65358173 P8363 Q65358173-60DF6791-7F6F-410A-9C9D-9C862AD52C9D @default.
- Q65358173 P1050 Q180614 @default.
- Q65358173 P1132 "+27" @default.
- Q65358173 P1476 "A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma" @default.
- Q65358173 P17 Q30 @default.
- Q65358173 P2899 "+19" @default.
- Q65358173 P3098 "NCT02138292" @default.
- Q65358173 P31 Q30612 @default.
- Q65358173 P4844 Q422222 @default.
- Q65358173 P4844 Q7833138 @default.
- Q65358173 P580 "2014-07-01T00:00:00Z" @default.
- Q65358173 P582 "2017-02-23T00:00:00Z" @default.
- Q65358173 P6099 Q5452194 @default.
- Q65358173 P6153 Q2725999 @default.
- Q65358173 P8363 Q78089383 @default.